Friday, December 18, 2020 6:40:10 PM
$CBLI & Cytocom $IMUN Phase 2 #COVID19 trial should be announced any day. Tremendously undervalued.$MRK $JNJ $ABBV $SGEN $BMRN $VRTX $AZN $SNY $GILD $ALXO $JPM $REGN $AMGN $BIIB $JAZZ #biotech $JAZZ $NVAX $INCY $GBT $HALO $KPTI $HTBX $cydy #Pennystocks #OTCStocks #OTCBB pic.twitter.com/GYOfOw2wbc
— Biotech (@ej23ny) December 16, 2020
FEATURED Element79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update • Oct 28, 2024 10:25 AM
VAYK Clarifies It Has No Business Connection to Persons Under SEC Charge • VAYK • Oct 28, 2024 11:59 AM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM